Novel diagnostic biomarkers discovery and validation for malaria sbir phase I
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93025C00004
- Awardee
-
L2 Diagnostics LLC UEI GKA7VH5LFR25
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Contract value 100% obligated
- $300,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New Haven, CT 06510, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Terminate for Convenience | $0 | |
| Original award | $300,000 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $300,000 Small Business Innovation Research (SBIR) Phase I contract to L2 Diagnostics LLC, a for-profit limited liability company based in Woodbridge, Connecticut. The contract, a Firm Fixed Price Definitive Contract with a performance period ending on November 30, 2025, is focused on discovering and validating novel diagnostic biomarkers for malaria. The contract is set aside for total small business participation. L2 Diagnostics LLC has previously received several significant NIAID grants for developing innovative vaccines and therapeutics for various infectious diseases, including Chikungunya virus, Lyme arthritis, and malaria. This SBIR Phase I contract represents the company's expertise in advanced medical interventions for complex infectious diseases.
Quick answers
Who was awarded contract 75N93025C00004?
75N93025C00004 was awarded to L2 Diagnostics LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2024.
How much is contract 75N93025C00004 worth?
The government has obligated $300,000 on 75N93025C00004.
Was contract 75N93025C00004 competed?
The extent of competition for 75N93025C00004 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award